COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.

Lin, Chung M A; Bennett, Josh; Rajagopala, Lavanya; Hunter, Ewan; Lorenzi, Alice R; Griffiths, Bridget; Baker, Kenneth F

Lin, Chung M A; Bennett, Josh; Rajagopala, Lavanya; Hunter, Ewan; Lorenzi, Alice R; Griffiths, Bridget; Baker, Kenneth F.

Afiliação

Lin CMA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Bennett J; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
Rajagopala L; Musculoskeletal Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Hunter E; Department of Infectious Diseases, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Lorenzi AR; Musculoskeletal Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Griffiths B; Musculoskeletal Unit, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Baker KF; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Rheumatology (Oxford) ; 62(6): e185-e187, 2023 06 01.

Article em En | MEDLINE | ID: mdl-36534829

Assuntos

Antirreumáticos; COVID-19; Doenças Reumáticas; Humanos; Doenças Reumáticas/tratamento farmacológico; Antirreumáticos/uso terapêutico; Antivirais/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Reumáticas / Antirreumáticos / COVID-19 Limite: Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google